智能注射器市场、智能注射器市场规模、智能注射器市场份额、智能注射器市场预测、智能注射器市场增长、智能注射器市场分析市场基于(主要地区、市场参与者、规模和份额)- 预测复合年增长率为 10.68%

  • Report Code : TIPMD00002257
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Smart Syringes Market Growth Report and Size by 2031

Buy Now

智能注射器市场规模预计将从 2023 年的 92.3 亿美元增至 2031 年的 208.3 亿美元。预计 2023-2031 年市场复合年增长率10.68%。对患者安全和减少错误的日益关注可能仍然是市场的主要趋势。

智能注射器市场分析

锐器伤,也称为经损伤,是指无意中通过刀片(例如手术刀)、注射器、针头或其他医疗器械刺入皮肤的事件。这些医疗器械可能会因刺伤或割伤皮肤而造成伤害。锐器伤主要与性传播疾病的职业传播有关。它们还与 20 多种其他病原体的传播有关。锐器伤害发生率的上升增加了对智能注射器的需求。

智能注射器市场概况

正如美国疾病控制与预防中心 (CDC) 在 2022 年强调的那样,每年因锐器伤害而职业性接触血源性病原体会导致医院医护人员遭受约 385,000 起针刺伤和其他与锐器相关的伤害。智能注射器旨在防止针刺伤并降低传播血源性疾病的风险。因此,通过不正确的注射操作导致乙型肝炎、丙型肝炎和艾滋病毒等血源性传播的高流行增加了安全注射器(包括智能注射器)的采用。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

智能注射器市场:

Smart Syringes Market: Strategic Insights

Smart Syringes Market

  • CAGR (2023 - 2031)
    10.68%
  • Market Size 2023
    US$ 9.23 Billion
  • Market Size 2031
    US$ 20.83 Billion

Key Players

  • Retractable Technologies, Inc
  • AdvaCare Pharma
  • Numedico Technologies Pty Ltd
  • Gerresheimer AG
  • Parker Hannifin Corp
  • BD
  • Cardinal Health
  • B. Braun Melsungen Ag
  • Terumo Corporation
  • Baxter

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

类型(主动安全注射器、被动安全注射器、自动禁用注射器)
    应用(疫苗接种、药物输送、血液样本采集)
      最终用户(医院和诊所、家庭护理、其他最终用户)

        智能注射器市场

        • 年均复合增长率(2023 - 2031) (2023 - 2031)
          10.68%
        • 2023 年市场规模
          92.3 亿美元
        • 2031 年市场规模
          208.3 亿美元

        市场动态

        增长动力
        • 锐器伤害发生率上升增加了对智能注射器的需求
        未来的趋势
        • 扩大注射器的治疗应用
        机会
        • 具有增强安全功能的智能电梯的出现带来了增长机会

        关键人物;主力;重要一员

        • 可伸缩技术公司
        • AdvaCare 制药公司 Pharma
        • Numedico 技术有限公司 Technologies Pty Ltd
        • 格雷斯海默股份公司 AG
        • 派克汉尼汾公司
        • BD
        • 康德乐
        • B. 布劳恩梅尔松根股份公司
        • 泰尔茂株式会社
        • 巴克斯特

        区域概况

        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        类型
        • 主动安全注射器
        • 被动安全注射器
        • 自动禁用注射器
        应用
        • 疫苗接种
        • 药物输送
        • 血液样本采集
        最终用户
        • 医院和诊所
        • 家庭护理
        • 其他最终用户
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        智能注射器市场驱动因素和机遇

        扩大注射器的治疗应用以青睐市场

        生物制剂和其他复杂、敏感药物的崛起需要精确和受控的给药。疫苗接种对于各种感染的一级预防至关重要,并通过提高对特定疾病的抵抗力来刺激身体产生针对病原体抗原的抗体。天花和脊髓灰质炎等几种疾病已通过疫苗接种成功消灭。此外,设计和技术的进步正在增加注射器在更复杂的输送程序中的使用,并具有卓越的功能,对智能注射器市场产生积极影响。因此,上述因素可能会推动预测期内智能注射器市场的增长。

        精准和个性化医疗需求带来增长机会

        在精准医疗和先进医疗工具的推动下,医疗保健领域正在经历一场创新变革。最前沿的是注射器,它是一种不可或缺的工具,已从基本的输送机制发展成为进行个性化和准确医疗的关键工具。集成人工智能算法以实现个性化剂量、自动错误检测和改进的数据分析,为患者提供支持并提高依从性。此外,为患者定制的预充式智能注射器的开发简化了患有复杂和慢性疾病的患者的自我给药。这鼓励自我管理健康并减少对医院常规注射的依赖。因此,此类技术进步被视为对市场产生积极影响,并可能带来增长机会。

        智能注射器市场报告细分分析

        有助于智能注射器市场分析的关键部分是类型、应用和最终用户。

        • 智能注射器市场根据类型分为主动安全注射器、被动安全注射器和自动禁用注射器。主动安全注射器细分市场在 2023 年占据最大的市场份额。
        • 按应用划分,市场分为疫苗接种、药物输送和血液样本采集。 2023 年,药物输送领域占据最大的市场份额。
        • 按最终用户划分,市场分为医院和诊所、家庭护理和其他最终用户。 2023 年,医院和诊所细分市场占据重要市场份额。

        按地区划分的智能注射器市场份额分析

        智能注射器市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲和中美洲。 预计亚太地区未来几年将以最高的复合年增长率增长。

        北美智能注射器市场以美国、加拿大、墨西哥三个主要国家为分析对象。据估计,到 2023 年,美国将在北美智能注射器市场中占据更大份额。该地区增长的特点是政府计划的增加和安全注射实践意识的提高。

        此外,市场参与者通过研发活动引入新的创新预计将在预测期内显着促进市场的增长。

        智能注射器市场报告范围

        报告属性细节
        2023年市场规模92.3亿美元
        2031 年市场规模208.3亿美元
        全球复合年增长率(2023 - 2031)10.68%
        历史数据2021-2022
        预测期2024-2031
        涵盖的细分市场按类型
        • 主动安全注射器
        • 被动安全注射器
        • 自动禁用注射器
        按申请
        • 疫苗接种
        • 药物输送
        • 血液样本采集
        按最终用户
        • 医院和诊所
        • 家庭护理
        • 其他最终用户
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        • 可伸缩技术公司
        • AdvaCare 制药公司
        • Numedico 技术有限公司
        • 格雷斯海默股份公司
        • 派克汉尼汾公司
        • BD
        • 康德乐
        • B. 布劳恩梅尔松根股份公司
        • 泰尔茂株式会社
        • 巴克斯特
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        智能注射器市场新闻和最新动态

        通过收集初级和二级研究的定性和定量数据来评估智能注射器市场,其中包括重要的公司出版物、协会数据和数据库。下面列出了智能注射器市场的一些发展:

        • Schott Pharma 推出了用于深冷药物的预填充聚合物注射器,可在温度达到 -100°C 的干冰上储存和运输。业界领先的公司目前正在寻求商业批准,以将 mRNA 应用与肖特制药的预充式聚合物注射器结合使用。展示注射器在极低温度下性能的科学数据包正在帮助制药公司将其药物推向市场。 (来源:肖特集团,新闻稿,2023 年 5 月)
        • Schreiner MediPharm 和 SCHOTT Pharma 合作推出了用于预充式注射器的新型 RFID 解决方案,以优化医院的日常工作。预充式注射器的数字化将为每个注射器提供独特的数字身份,从而改善医院库存管理和患者护理。此外,它将包括一个数字首次打开指示器,以保护注射器的完整性。 (来源:Schreiner MediPharm,新闻稿,2022 年 11 月)

        智能注射器市场报告的覆盖范围和可交付成果

        《智能注射器市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

        • 智能注射器市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
        • 智能注射器制造市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
        • 详细的 PEST/波特五力分析和 SWOT 分析
        • 智能注射器市场分析,涵盖主要市场趋势、全球和区域框架、重要参与者、法规和最新市场发展
        • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者以及智能注射器市场的最新发展
        • 详细的公司简介

        Smart Syringes Market Report Scope

        Report Attribute Details
        Market size in US$ 9.23 Billion
        Market Size by US$ 20.83 Billion
        Global CAGR 10.68%
        Historical Data 2021-2022
        Forecast period 2024-2031
        Segments Covered By 类型(主动安全注射器、被动安全注射器、自动禁用注射器)
        By 应用(疫苗接种、药物输送、血液样本采集)
        By 最终用户(医院和诊所、家庭护理、其他最终用户)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Retractable Technologies, Inc
      • AdvaCare Pharma
      • Numedico Technologies Pty Ltd
      • Gerresheimer AG
      • Parker Hannifin Corp
      • BD
      • Cardinal Health
      • B. Braun Melsungen Ag
      • Terumo Corporation
      • Baxter
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        Frequently Asked Questions


        Which region dominated the smart syringes market in 2023?

        North America dominated the smart syringes market in 2023.

        What are the driving factors impacting the smart syringes market?

        Factors Including the rising incidences of sharp injuries and expanding therapeutic applications of syringes are the driving factors for the smart syringes market growth.

        What are the future trends of the smart syringes market?

        The growing focus on patient safety and error reduction are future trends in the market.

        Which are the leading players operating in the smart syringes market?

        Retractable Technologies, Inc.; AdvaCare Pharma; Numedico Technologies Pty Ltd; Gerresheimer AG; Parker Hannifin Corp; BD; Cardinal Health; B. Braun Melsungen Ag; Terumo Corporation; and Baxter are some leading players operating in the smart syringes market.

        What would be the estimated value of the smart syringes market by 2031?

        The smart syringes market is estimated to reach US$ 20.83 billion by 2031.

        What is the expected CAGR of the smart syringes market?

        The smart syringes market is anticipated to grow at a CAGR of 10.68% during 2023-2031.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Related Reports